List of Tables
Table 1. Female Oral Contraceptives Market Trends
Table 2. Female Oral Contraceptives Market Drivers & Opportunity
Table 3. Female Oral Contraceptives Market Challenges
Table 4. Female Oral Contraceptives Market Restraints
Table 5. Global Female Oral Contraceptives Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Female Oral Contraceptives Revenue Market Share by Company (2019-2024)
Table 7. Global Female Oral Contraceptives Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Female Oral Contraceptives Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Female Oral Contraceptives Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Female Oral Contraceptives Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Female Oral Contraceptives Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Female Oral Contraceptives
Table 13. Global Female Oral Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Oral Contraceptives as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Female Oral Contraceptives Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Female Oral Contraceptives Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Female Oral Contraceptives Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Female Oral Contraceptives Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Female Oral Contraceptives Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Female Oral Contraceptives Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Female Oral Contraceptives Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Female Oral Contraceptives Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Female Oral Contraceptives Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Female Oral Contraceptives Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Female Oral Contraceptives Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Female Oral Contraceptives Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Female Oral Contraceptives Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Female Oral Contraceptives Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Female Oral Contraceptives Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Female Oral Contraceptives Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Female Oral Contraceptives Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Female Oral Contraceptives Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Female Oral Contraceptives Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Female Oral Contraceptives Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Female Oral Contraceptives Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Female Oral Contraceptives Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Female Oral Contraceptives Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Female Oral Contraceptives Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Female Oral Contraceptives Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Female Oral Contraceptives Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Female Oral Contraceptives Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Female Oral Contraceptives Sales Value by Region (2019-2024) & (%)
Table 44. Global Female Oral Contraceptives Sales Value by Region (2025-2030) & (%)
Table 45. Global Female Oral Contraceptives Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Female Oral Contraceptives Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Female Oral Contraceptives Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Female Oral Contraceptives Sales Volume by Region (2019-2024) & (%)
Table 49. Global Female Oral Contraceptives Sales Volume by Region (2025-2030) & (%)
Table 50. Global Female Oral Contraceptives Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Female Oral Contraceptives Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Female Oral Contraceptives Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Female Oral Contraceptives Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Female Oral Contraceptives Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Female Oral Contraceptives Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Female Oral Contraceptives Sales Volume, (2025-2030) & (K Units)
Table 57. Bayer Company Information
Table 58. Bayer Introduction and Business Overview
Table 59. Bayer Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bayer Female Oral Contraceptives Product Offerings
Table 61. Bayer Recent Development
Table 62. Janssen Global Services Company Information
Table 63. Janssen Global Services Introduction and Business Overview
Table 64. Janssen Global Services Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Janssen Global Services Female Oral Contraceptives Product Offerings
Table 66. Janssen Global Services Recent Development
Table 67. Allergan,plc (Actavis) Company Information
Table 68. Allergan,plc (Actavis) Introduction and Business Overview
Table 69. Allergan,plc (Actavis) Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Allergan,plc (Actavis) Female Oral Contraceptives Product Offerings
Table 71. Allergan,plc (Actavis) Recent Development
Table 72. Teva Pharmaceutical Company Information
Table 73. Teva Pharmaceutical Introduction and Business Overview
Table 74. Teva Pharmaceutical Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Teva Pharmaceutical Female Oral Contraceptives Product Offerings
Table 76. Teva Pharmaceutical Recent Development
Table 77. Piramal Enterprises Company Information
Table 78. Piramal Enterprises Introduction and Business Overview
Table 79. Piramal Enterprises Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Piramal Enterprises Female Oral Contraceptives Product Offerings
Table 81. Piramal Enterprises Recent Development
Table 82. Pfizer Company Information
Table 83. Pfizer Introduction and Business Overview
Table 84. Pfizer Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Pfizer Female Oral Contraceptives Product Offerings
Table 86. Pfizer Recent Development
Table 87. Merck Company Information
Table 88. Merck Introduction and Business Overview
Table 89. Merck Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Merck Female Oral Contraceptives Product Offerings
Table 91. Merck Recent Development
Table 92. Mankind Pharma Company Information
Table 93. Mankind Pharma Introduction and Business Overview
Table 94. Mankind Pharma Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Mankind Pharma Female Oral Contraceptives Product Offerings
Table 96. Mankind Pharma Recent Development
Table 97. Syzygy Healthcare Company Information
Table 98. Syzygy Healthcare Introduction and Business Overview
Table 99. Syzygy Healthcare Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Syzygy Healthcare Female Oral Contraceptives Product Offerings
Table 101. Syzygy Healthcare Recent Development
Table 102. Ferring B.V Company Information
Table 103. Ferring B.V Introduction and Business Overview
Table 104. Ferring B.V Female Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Ferring B.V Female Oral Contraceptives Product Offerings
Table 106. Ferring B.V Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Female Oral Contraceptives Downstream Customers
Table 110. Female Oral Contraceptives Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Female Oral Contraceptives Product Picture
Figure 2. Global Female Oral Contraceptives Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Female Oral Contraceptives Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Female Oral Contraceptives Sales Volume (2019-2030) & (K Units)
Figure 5. Global Female Oral Contraceptives Sales Price (2019-2030) & (US$/Unit)
Figure 6. Female Oral Contraceptives Report Years Considered
Figure 7. Global Female Oral Contraceptives Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Female Oral Contraceptives Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Female Oral Contraceptives Revenue in 2023
Figure 10. Female Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Combination Pill Picture
Figure 12. Progestin-only Pill Picture
Figure 13. Continuous Use Pill Picture
Figure 14. Global Female Oral Contraceptives Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Female Oral Contraceptives Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Female Oral Contraceptives Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Female Oral Contraceptives Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Female Oral Contraceptives Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Online Sales
Figure 20. Product Picture of Offline Sales
Figure 21. Global Female Oral Contraceptives Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Female Oral Contraceptives Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Female Oral Contraceptives Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Female Oral Contraceptives Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Female Oral Contraceptives Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Female Oral Contraceptives Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Female Oral Contraceptives Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Female Oral Contraceptives Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Female Oral Contraceptives Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Female Oral Contraceptives Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Female Oral Contraceptives Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Female Oral Contraceptives Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Female Oral Contraceptives Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Female Oral Contraceptives Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Female Oral Contraceptives Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Female Oral Contraceptives Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Female Oral Contraceptives Sales Volume (%), (2019-2030)
Figure 38. United States Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 44. China Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 46. China Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 56. India Female Oral Contraceptives Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Female Oral Contraceptives Sales Value by Type (%), 2023 VS 2030
Figure 58. India Female Oral Contraceptives Sales Value by Application (%), 2023 VS 2030
Figure 59. Female Oral Contraceptives Industrial Chain
Figure 60. Female Oral Contraceptives Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
